Northwestern Mutual Wealth Management’s Cellectar Biosciences, Inc. CLRBW Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CLRBW Stock Details CLRBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-320	Closed	–	–	2733
2018 Q2	$0	Hold	320	–	–	﹤0.01%	2559
2018 Q1	$0	Hold	320	–	–	﹤0.01%	2517
2017 Q4	$0	Hold	320	–	–	﹤0.01%	2519
2017 Q3	$0	Hold	320	–	–	﹤0.01%	2338
2017 Q2	$0	Hold	320	–	–	﹤0.01%	2229
2017 Q1	$0	Hold	320	–	–	﹤0.01%	2571
2016 Q4	$0	Buy	+320	New	+$72	﹤0.01%	2404
2016 Q3	–	Sell	-320	Closed	–	–	1793
2016 Q2	$0	Hold	320	–	–	﹤0.01%	2334
2016 Q1	$0	Buy	+320	New	+$968	﹤0.01%	2349

Other funds holding CLRBW

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northwestern Mutual Wealth Management's CLRBW Position: Q3 2018 in Review

Northwestern Mutual Wealth Management sold out of Cellectar Biosciences, Inc. (CLRBW) in Q3 2018, closing a stake of 320 shares.

Northwestern Mutual Wealth Management first reported a position in CLRBW in Q1 2016 and held it in 9 quarters. The position peaked at $0 in Q2 2018. 4 funds tracked by Wall St. Rank hold CLRBW as of Q3 2018.

Northwestern Mutual Wealth Management reported no remaining Cellectar Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 320 Cellectar Biosciences, Inc. shares in Q3 2018.
Northwestern Mutual Wealth Management first reported a position in Cellectar Biosciences, Inc. in Q1 2016 and held it in 9 quarters.
Northwestern Mutual Wealth Management's Cellectar Biosciences, Inc. position peaked at $0 in Q2 2018.
4 funds tracked by Wall St. Rank held Cellectar Biosciences, Inc. as of Q3 2018.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2018, filed 1 Nov 2018.